. Author manuscript; available in PMC: 2010 Sep 1.

Published in final edited form as: Muscle Nerve. 2009 Sep;40(3):363–370. doi: 10.1002/mus.21332

Table 1.

Patient and Disease Characteristics of the Transthyretin Amyloidosis Cohort

Number	36
Male gender (number, %)	31 (86%)
Weight (kg), median (range)	74 (38.1 – 122.5)
Height (m), median (range)	1.77 (1.58 – 1.96)
Body mass index (kg/m²), median (range)	24.1 (15.4 – 38.8)
Age at initial symptom onset (years), median (range)	53 (18–75)
Below 50 year old, cases (%)	16 (44%)
Above 50 year old, cases (%)	20 (56%)
Age at first Mayo Clinic evaluation (years), median (range)	59 (23 – 78)
Duration from symptom onset to first Mayo Clinic evaluation (years), median (range)	4 (1 – 30)
History of clinical or electrophysiologic CTS, cases (%)	14 (39%)
History of carpal tunnel release, cases (%)	9 (25%)
Gene mutations, cases (%)
Val30Met	14 (39%)
Thr60Ala	5 (14%)
The others^*	11 (28%)
Not detected^†	7 (19)

CTS, carpal tunnel syndrome

Asp38Ala, Gly47Glu, and Ser77Tyr, 2 cases respectively; Pro24Ser, Phe33Leu, Als45Asp, Phe64Leu, and Ala109Ser, 1 case respectively

^†

Patients who could not be identified on genetic test because of limitation of TTR mutant genes tested.